166 related articles for article (PubMed ID: 27469532)
21. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
[TBL] [Abstract][Full Text] [Related]
22. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
23. The MATE1 rs2289669 polymorphism affects the renal clearance of metformin following ranitidine treatment.
Cho SK; Chung JY
Int J Clin Pharmacol Ther; 2016 Apr; 54(4):253-62. PubMed ID: 26784938
[TBL] [Abstract][Full Text] [Related]
24. Moxifloxacin Is a Potent In Vitro Inhibitor of OCT- and MATE-Mediated Transport of Metformin and Ethambutol.
Te Brake LH; van den Heuvel JJ; Buaben AO; van Crevel R; Bilos A; Russel FG; Aarnoutse RE; Koenderink JB
Antimicrob Agents Chemother; 2016 Dec; 60(12):7105-7114. PubMed ID: 27645247
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution and ontogeny of organic cation transporters in mice.
Alnouti Y; Petrick JS; Klaassen CD
Drug Metab Dispos; 2006 Mar; 34(3):477-82. PubMed ID: 16381671
[TBL] [Abstract][Full Text] [Related]
26. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin.
Tzvetkov MV; Vormfelde SV; Balen D; Meineke I; Schmidt T; Sehrt D; Sabolić I; Koepsell H; Brockmöller J
Clin Pharmacol Ther; 2009 Sep; 86(3):299-306. PubMed ID: 19536068
[TBL] [Abstract][Full Text] [Related]
27. Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [(11)C]Metformin in Mouse.
Shingaki T; Hume WE; Takashima T; Katayama Y; Okauchi T; Hayashinaka E; Wada Y; Cui Y; Kusuhara H; Sugiyama Y; Watanabe Y
Pharm Res; 2015 Aug; 32(8):2538-47. PubMed ID: 25715695
[TBL] [Abstract][Full Text] [Related]
28. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
[TBL] [Abstract][Full Text] [Related]
29. Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families.
Chen J; Brockmöller J; Seitz T; König J; Chen X; Tzvetkov MV
Biol Chem; 2017 Feb; 398(2):237-249. PubMed ID: 27676604
[TBL] [Abstract][Full Text] [Related]
30. Transport Turnover Rates for Human OCT2 and MATE1 Expressed in Chinese Hamster Ovary Cells.
Zhang X; Wright SH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163393
[TBL] [Abstract][Full Text] [Related]
31. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
[TBL] [Abstract][Full Text] [Related]
32. Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins.
Kato K; Mori H; Kito T; Yokochi M; Ito S; Inoue K; Yonezawa A; Katsura T; Kumagai Y; Yuasa H; Moriyama Y; Inui K; Kusuhara H; Sugiyama Y
Pharm Res; 2014 Jan; 31(1):136-47. PubMed ID: 23907530
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenetic variation and metformin response.
Chen S; Zhou J; Xi M; Jia Y; Wong Y; Zhao J; Ding L; Zhang J; Wen A
Curr Drug Metab; 2013 Dec; 14(10):1070-82. PubMed ID: 24329113
[TBL] [Abstract][Full Text] [Related]
34. Multidrug and toxin extrusion protein 1-mediated interaction of metformin and Scutellariae radix in rats.
Yim S; You BH; Chae HS; Chin YW; Kim H; Choi HS; Choi YH
Xenobiotica; 2017 Nov; 47(11):998-1007. PubMed ID: 27817253
[TBL] [Abstract][Full Text] [Related]
35. Role of age-related decrease of renal organic cation transporter 2 in the effect of atenolol on renal excretion of metformin in rats.
Ren J; Zhou Y; Zhang G; Zhou L; Zhao J; Wei Y; Wu X
Eur J Drug Metab Pharmacokinet; 2015 Sep; 40(3):349-54. PubMed ID: 24981592
[TBL] [Abstract][Full Text] [Related]
36. Hormonal regulation of organic cation transporter OCT2 expression in rat kidney.
Urakami Y; Okuda M; Saito H; Inui K
FEBS Lett; 2000 May; 473(2):173-6. PubMed ID: 10812069
[TBL] [Abstract][Full Text] [Related]
37. Divergent Regulation of OCT and MATE Drug Transporters by Cadmium Exposure.
Yang H; Zhou S; Guo D; Obianom ON; Li Q; Shu Y
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924306
[TBL] [Abstract][Full Text] [Related]
38. Genetic variation in organic cation transporters and considerations in drug development.
Varma MVS
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):149-164. PubMed ID: 37070463
[TBL] [Abstract][Full Text] [Related]
39. Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats.
Ma YR; Qin HY; Jin YW; Huang J; Han M; Wang XD; Zhang GQ; Zhou Y; Rao Z; Wu XA
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):559-65. PubMed ID: 25876759
[TBL] [Abstract][Full Text] [Related]
40. The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine.
Xiao L; Xue Y; Zhang C; Wang L; Lin Y; Pan G
Xenobiotica; 2018 Mar; 48(3):314-323. PubMed ID: 28298174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
